BabelNet

bn:02908795n

Noun Named Entity

No term available

RO-4491533 is a drug developed by Hoffmann-La Roche which acts as a potent and selective negative allosteric modulator for group II of the metabotropic glutamate receptors, being equipotent at mGluR2 and mGluR3 but without activity at other mGluR subtypes. Wikipedia

Relations

Sources

IS A

composé chimique

PHYSICALLY INTERACTS WITH

GRM2

GRM3